A possible dopaminergic mechanism in the serotonergic antidepressant-induced sexual dysfunctions

Journal of Sex and Marital Therapy

Volumn 25, Issue 2, 1999, Pages 125-129

  Alcantara A G ^a  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMESERGIDE; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG INDUCED DISEASE; MEDIAL PREOPTIC AREA; NONHUMAN; PRESYNAPTIC INHIBITION; RAT; RECEPTOR UPREGULATION; SEROTONINERGIC TRANSMISSION; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; DOPAMINE; HUMANS; MALE; NOREPINEPHRINE; ORGASM; RATS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 0345003782     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926239908403985     Document Type: Article

References (35)

1. Aizenberg, D., Gur, S., Zemishlany, Z., Granek, M., Jeczmien, P., & Weizman, A. (1997). Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clinical Neuropharmacology, 20, 210-214.
2. Aizenberg, D., Zemishlany, Z., & Weizman, A. (1995). Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clinical Neuropharmacology, 18, 320-324.
3. Albinsson, A., Andersson, G., Andersson, K, Vega-Matuszczyk, J., & Larsson, K. (1996). The effects of lesions in the mesencephalic raphe systems on male rat sexual behavior and locomotor activity. Behav Brain Research, 80, 57-63.
4. Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C, Golden, R. N., Martin, P., Potter, W. Z., Richelson, E., & Sulser, F. (1995). Bupropion: A review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry, 56, 395-401.
5. Balogh, S., Hendricks, S. E., & Kang, J. (1992). Treatment of fluoxetine-induced anor-gasmia with amantadine. Journal of Clinical Psychiatry, 53, 212-213.
6. Balon, R. (1996). Intermittent amantadine for fluoxetine-induced anorgasmia. Journal of Sex and Marital Therapy, 22, 290-292.
7. Bartlik, B. D., Kaplan, P., & Kaplan, H. S. (1995). Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. Journal of Sex and Marital Therapy, 21, 264-271.
8. Cohen, A. J. (1992). Fluoxetine-induced yawning and anorgasmia reversed by cyproheptadine treatment. Journal of Clinical Psychiatry, 53, 174.
9. Cooper, B. R., Wang, C. M., Cox, R. F., Norton, R., Shea, V., & Ferris, R. M. (1994). Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) area mediated by a noradrenergic mechanism. Neuropsychopharmacol-ogy, 11, 133-141.
10. DeCastro, R. M. (1985). Reversal of a MAOI-induced anorgasmia with cyproheptadine. American Journal of Psychiatry, 142, 783.
11. Done, C. J., & Sharp, T. (1992). Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo. British Journal of Pharmacology, 107, 240-245.
12. Done, C. J., & Sharp, T. (1994). Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: Microdialysis studies in the awake and anaesthetized rat. Neuropharmacology, 33, 411-421.
13. Feiger, A., Kiev, A., Shrivastava, R. K., Wisselink, P. G., & Wilcox, C. S. (1996). Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. Journal of Clinical Psychiatry, 57 Suppl. 2, 53-62.
14. Foreman, M. M., Fuller, R. W., Nelson, D. L., Calligaro, D. O., Kurz, K. D., Misner, J. W., Garbrecht, W. L., & Parli, C.J. (1992). Preclinical studies on LY237733, a potent and selective serotonergic antagonist. Journal of Pharmacol Exp Ther, 260, 51-57.
15. Hillegaart, V., Ahlenius, S., & Larsson, K. (1991). Region-selective inhibition of male rat sexual behavior and motor performance by localized forebrain 5-HT injections: A comparison with effects produced by 8-OH-DPAT. Behav Brain Res, 42, 169-180.
16. Hollander, E., & McCarley, A. (1992). Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. Journal of Clinical Psychiatry, 53, 207-209.
17. Hull, E. M., Eaton, R. C, Moses, J., & Lorrain, D. (1993). Copulation increases dopamine activity in the medial preoptic area of male rats. Life Science, 52, 935-940.
18. Kapur, S., & Remington, G. (1996). Serotonin-dopamine interaction and its relevance to schizophrenia. American Journal of Psychiatry, 153, 466-476.
19. Keller Ashton, A., Hamer, R., & Rosen, R. C. (1997). Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large-scale retrospective study of 596 psychiatric outpatients. Journal of Sex and Marital Therapy, 23, 65-75.
20. Klint, T., Dahlgren, I. L., & Larsson, K. (1992). The selective 5-HT2 receptor antagonist amperozide attenuates l-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior. European Journal of Pharmacology, 212, 241-246.
21. Lauerma, H. (1996). Successful treatment of citalopram-induced anorgasmia by cyproheptadine. Acta Psychiatr Scandinavia, 93, 69-70.
22. Mas, M., Rodriguez del Castillo, A., Guerra, M., Davidson, J. M., & Battaner, E. (1987). Neurochemical correlates of male sexual behavior. Physiol Behav, 41, 341-345.
23. McCormick, S., Olin, J., & Brotman, A. W. (1990). Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. Journal of Clinical Psychiatry, 51, 383-384.
24. Menendez Abraham, E., Moran Viesca, P., Velasco Plaza, A., & Marin, G. (1988). Modifications of the sexual activity in male rats following administration of antiserotoniner-gic drugs. Behav Brain Res, 30, 251-258.
25. Modell, J. G., Katholi, C. R., Modell, J. D., & DePalma, L. (1997). Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther, 61, 476-487.
26. Montejo-Gonzalez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousofto, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De la Gándara, J., et al. (1997). SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. Journal of Sex and Marital Therapy, 23, 176-194.
27. Price, J., & Grunhaus, L.J. (1990). Treatment of clomipramine-induced anorgasmia with yohimbine: A case report. Journal of Clinical Psychiatry, 51, 32-33.
28. Riley, A. J., & Riley, E. J. (1986). Cyproheptadine and antidepressant-induced anorgasmia. British Journal of Psychiatry, 148, 217-218.
29. Segraves, R. T. (1995). Antidepressant-induced orgasm disorder. Journal of Sex and Marital Therapy, 21, 192-201.
30. Sovner, R. (1984). Treatment of tricyclic antidepressant-induced orgasmic with cyproheptadine. Journal of Clinical Psychopharmacology, 4, 169.
31. Steele, T. E., & Howell, E. F. (1986). Cyproheptadine for imipramine-induced anorgasmia. Journal of Clinical Psychopharmacology, 6, 326-327.
32. Ugedo, L., Grenhoff, J., & Svensson, T. H. (1989). Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology, 98, 45-50.
33. Verma, S., Chhina, G. S., Mohan, V., & Singh, B. (1989). Inhibition of male sexual behavior by serotonin application in the medial preoptic area. Physiol Behav, 46, 327-330.
34. Watson, N. V., & Gorzalka, B. B. (1991). DOI-induced inhibition of copulatory behavior in male rats: Reversal by 5-HT2 antagonists. Pharmacol Biochem Behav, 39, 605-612.
35. Watson, N. V., & Gorzalka, B. B. (1992). Concurrent wet dog shaking and inhibition of male rat copulation after ventromedial brainstem injection of the 5-HT2 agonist DOI. Neuroscience Letter, 14, 25-29.